HYSTERI: Hysterectomy - A Regional Intervention Study

Sponsor
University Hospital, Linkoeping (Other)
Overall Status
Recruiting
CT.gov ID
NCT05255120
Collaborator
(none)
320
2
2
38.8
160
4.1

Study Details

Study Description

Brief Summary

Approximately 4,000 procedures with hysterectomy for benign indication are performed annually in Sweden. There are large differences in preoperative information, planning of surgery and surgical technique. A structured approach including the use of mobile phone technology can possibly improve patient information and patient involvement. Our purpose is to to evaluate whether systematic preoperative preparation improves the outcome of elective hysterectomy on benign indication.

Condition or Disease Intervention/Treatment Phase
  • Other: Intiensified structured perioperative information
N/A

Detailed Description

Background Approximately 4,000 procedures with hysterectomy for benign indication are performed annually in Sweden. There are large differences between clinics in Sweden in the proportion of hysterectomies conducted using minimally invasive surgery. There is no uniformity in the planning of surgery. Patient-reported outcome measures, such as satisfaction and postoperatively unexpected symptoms, are important in assessing the outcome of surgery. Patient-reported measurements are, besides other factors, dependent on preoperative information. Mobile phone technology can possibly improve patient information and patient involvement.

Purpose

To evaluate whether a systematic preoperative preparation improves the outcome of elective hysterectomy on benign indication. The work consists of three parts with the following purposes:

Sub-study 1: To evaluate the effect of a preoperative algorithm for determining the most appropriate method of hysterectomy on the proportion undergoing surgery as a minimally invasive procedure and on the frequency of complications.

Sub-study 2: To compare patient-reported outcome measures, including unexpected symptoms, recovery, and satisfaction, in women who receive systematic preoperative information from specially trained staff and a mobile application with targeted education on the procedure, with women who receive information according to normal routines.

Sub-study 3: To investigate how women experience digitized information via a mobile application in connection with surgery.

Participating centers Departments of obstetrics and gynecology at the hospitals in Norrköping, Jönköping, Eksjö, Värnamo, Västervik, Kalmar and Växjö.

Schedule The study starts in September 2020. Recruitment of patients is planned to take two years.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
320 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
The Effect of Systematic Preoperative Preparation on the Outcome of Benign Hysterectomy: a Prospective Intervention Study
Actual Study Start Date :
Sep 4, 2020
Anticipated Primary Completion Date :
Aug 31, 2022
Anticipated Study Completion Date :
Nov 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intensified preoperative information

The patient participating in the intervention group is evaluated preoperatively based on an algorithm. This information is designed according to a checklist which includes how the procedure is performed, rules of conduct in connection with and after the procedure and what the patient can expect after surgery.

Other: Intiensified structured perioperative information
The doctor takes a medical history and examines the patient according to regular routines, but uses the algorithm as support in deciding on the surgical method. After the doctor's visit, the patient must see a research nurse to receive the intensified preoperative information about hysterectomy. This information is designed according to a checklist. The patient can also download a mobile application. The study-specific mobile application (app) contains information about hysterectomy. The information is structured in three parts - Before the Operation, At the Hospital and After the Operation. A timeline describes the activities and events that occur before, around and after the operation. Within each section there are several information links, with eg checklists.

No Intervention: Control group

The patient who participates in the control group receives information about participation in the study as a control, ie without information about the intervention. The patient will then be planned for the procedure according to current, local routines.

Outcome Measures

Primary Outcome Measures

  1. Unexpected postoperative symtoms [Up to one year postoperatively]

    Proportion of patients with unexpected symptoms.

  2. Proportion minimally invasive hysterectomy [Retrospecive data 5 years before study start until completion of prospective study]

    Proportion of women undergoing hysterectomy as a minimally invasive procedure

Secondary Outcome Measures

  1. Complication [Up to one year postoperatively]

    Numbers of and types of patient reported complications

  2. Lenght of stay [Day of surgery until discharge from hospital pre- and during the intervention]

    Hospital length of stay in connection with surgery

  3. Sick leave [Day of discharge from hospital after surgery until return to normal work, maximal one year]

    return to work measured as actual sick leave length

  4. Recovery [Day of surgery until normal ADL, maximal one year]

    time to normal daily activity (ADL)

  5. Health related quality of life [Preoperatively up to one year postoperatively]

    Measured with EuroQol EQ-5D-3L health index comprising of two parts. Part A Scale -0.5941 to 1. A higher number indicates better quality of life. Part B. EuroQol visual analoque scale EQ-VAS. Scale 0-100. A higher number indicates better quality of life

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 55 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Women 18 - 55 years old.

  • Women undergoing hysterectomy for benign indication.

  • Women with ASA 1 - 3.

  • Women who understand and can express themselves in Swedish.

  • Women who, by signing "Informed Consent", agree to participate in the study after written and oral information.

  • Women who participate and respond to the surveys in the GynOp register.

  • Women who have access to an I-phone, smartphone, computer or tablet and who can use the study-specific mobile application. (Does not apply to sub-study 1).

Exclusion criteria

  • Women where both ovaries are removed during the operation.

  • Women undergoing hysterectomy for prolapse indication.

  • Women undergoing hysterectomy for cancer prophylactic indication.

  • Women undergoing hysterectomy for gender reassignment purposes.

  • Women with intellectual disabilities to such an extent that they can not fill in the relevant questionnaires etc. or if they do not understand the meaning of participating in the study or where there may be ethical doubts about the patient's participation in the study.

  • Women who have a mental illness of such severity that the doctor in charge considers it inappropriate for the patient to be included in the study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Hospital Linköping Sweden 58185
2 Vrinnevisjukhuset Norrköping Sweden 58185

Sponsors and Collaborators

  • University Hospital, Linkoeping

Investigators

  • Study Chair: Preben Kjölhede, MD PhD, University Hospital, Linköing
  • Study Chair: Lollo Makdessi, MD, Vrinnevi Hospital, Norrköping

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Preben Kjolhede, MD, professor, Professor, University Hospital, Linkoeping
ClinicalTrials.gov Identifier:
NCT05255120
Other Study ID Numbers:
  • HYSTERI
First Posted:
Feb 24, 2022
Last Update Posted:
Mar 14, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Mar 14, 2022